*These authors contributed equally to this work.
Article first published online: 27 MAY 2013
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 58, Issue 1, pages 388–396, July 2013
How to Cite
Chen, M., Borlak, J. and Tong, W. (2013), High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology, 58: 388–396. doi: 10.1002/hep.26208
Potential conflict of interest: Nothing to report.
Supported by the German Federal Ministry for Education and Research as part of the Virtual Liver Network initiative (grant 031 6154 to J.B.). J.B. is a recipient of an ORISE Stipend of the US Food and Drug Administration.
The views presented in this article do not necessarily reflect those of the US Food and Drug Administration.
- Issue published online: 24 JUN 2013
- Article first published online: 27 MAY 2013
- Accepted manuscript online: 19 DEC 2012 11:42AM EST
- Manuscript Accepted: 11 DEC 2012
- Manuscript Received: 24 AUG 2012
This article has been cited by:
- 1A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the ‘rule-of-two’ model, Archives of Toxicology, 2014, 88, 7, 1439, , , , , , , ,
- 2Acute liver failure following atorvastatin dose escalation: Is there a threshold dose for idiosyncratic hepatotoxicity?, Journal of Hepatology, 2014,, , , ,
- 3Age-related differences in reporting of drug-associated liver injury: Data-mining of WHO Safety Report Database, Regulatory Toxicology and Pharmacology, 2014, 70, 2, 519, , , ,
- 4Can Nucleos(t)ide Analogue (NA) Therapy Ever be Stopped in HBeAg-Negative Chronic Hepatitis B?, Current Hepatology Reports, 2014, 13, 3, 256, , , ,
- You have free access to this content5
- 6Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting, Journal of Hepatology, 2014, 60, 4, 872, ,
- 7Drug-Induced Liver Injury, Mayo Clinic Proceedings, 2014, 89, 1, 95, , ,
- 8Drug-Induced Liver Injury, Dosage, and Drug Disposition: Is Idiosyncrasy Really Unpredictable?, Clinical Gastroenterology and Hepatology, 2014, 12, 9, 1556,
- 9Drug-induced liver injury: what was new in 2013?, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 7, 959, , , ,
- 11Mechanisms of drug-induced liver injury, Current Opinion in Allergy and Clinical Immunology, 2014, 14, 4, 286, , ,
- 12Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives, Gastroenterology, 2014, 146, 4, 914,
- 13Predicting idiosyncratic drug-induced liver injury – some recent advances, Expert Review of Gastroenterology & Hepatology, 2014, 8, 7, 721, , ,
- 14Relationship Between Characteristics of Medications and Drug-Induced Liver Disease Phenotype and Outcome, Clinical Gastroenterology and Hepatology, 2014, 12, 9, 1550, , , , , , , , ,
- 15Toward predictive models for drug-induced liver injury in humans: are we there yet?, Biomarkers in Medicine, 2014, 8, 2, 201, , , , , , ,
- 18Quantitative Structure-Activity Relationship Models for Predicting Drug-Induced Liver Injury Based on FDA-Approved Drug Labeling Annotation and Using a Large Collection of Drugs, Toxicological Sciences, 2013, 136, 1, 242, , , , , , ,